Have a feature idea you'd love to see implemented?
Let us know!
BHC Bausch Health Companies Inc
Price (delayed)
$7.94
Market cap
$2.92B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.47
Enterprise value
$23.68B
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of
Highlights
The net income has soared by 82% YoY and by 62% from the previous quarter
BHC's EPS has surged by 82% year-on-year and by 63% since the previous quarter
Bausch Health Companies's quick ratio has decreased by 3.1% YoY
Key stats
What are the main financial stats of BHC
Market
Valuations
Earnings
Shares outstanding
367.8M
Market cap
$2.92B
Enterprise value
$23.68B
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
0.31
EV/EBIT
16.86
EV/EBITDA
8.79
EV/Sales
2.5
Revenue
$9.47B
Gross profit
$6.71B
Net income
-$178M
EBIT
$1.4B
EBITDA
$2.69B
Free cash flow
$1.01B
Per share
Balance sheet
Liquidity
EPS
-$0.47
EPS diluted
-$0.47
Free cash flow per share
$2.74
Book value per share
-$3.2
Revenue per share
$25.72
TBVPS
$26.38
Total assets
$26.54B
Total liabilities
$26.78B
Debt
$21.51B
Equity
-$1.17B
Working capital
$845M
Debt to equity
-18.32
Current ratio
1.19
Quick ratio
0.63
Net debt/EBITDA
7.71
Margins
Efficiency
Dividend
EBITDA margin
28.4%
Gross margin
70.9%
Net margin
-1.9%
Operating margin
14.2%
Return on assets
-0.7%
Return on equity
N/A
Return on invested capital
5.3%
Return on capital employed
6.4%
Return on sales
14.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BHC stock price
How has the Bausch Health Companies stock price performed over time
Intraday
-1.49%
1 week
4.34%
1 month
1.53%
1 year
2.06%
YTD
-1.49%
QTD
-1.49%
Financial performance
How have Bausch Health Companies's revenue and profit performed over time
Revenue
$9.47B
Gross profit
$6.71B
Operating income
$1.35B
Net income
-$178M
Gross margin
70.9%
Net margin
-1.9%
The net margin has surged by 83% year-on-year and by 63% since the previous quarter
The net income has soared by 82% YoY and by 62% from the previous quarter
The company's operating income rose by 29% QoQ
The operating margin has grown by 25% from the previous quarter
Growth
What is Bausch Health Companies's growth rate over time
Valuation
What is Bausch Health Companies stock price valuation
P/E
N/A
P/B
N/A
P/S
0.31
EV/EBIT
16.86
EV/EBITDA
8.79
EV/Sales
2.5
BHC's EPS has surged by 82% year-on-year and by 63% since the previous quarter
The price to sales (P/S) is 56% lower than the 5-year quarterly average of 0.7 but 3.3% higher than the last 4 quarters average of 0.3
The revenue has increased by 11% year-on-year and by 3% since the previous quarter
Efficiency
How efficient is Bausch Health Companies business performance
BHC's return on invested capital has surged by 141% year-on-year and by 29% since the previous quarter
BHC's return on sales has surged by 131% year-on-year and by 25% since the previous quarter
The ROA has soared by 81% YoY and by 59% from the previous quarter
Dividends
What is BHC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BHC.
Financial health
How did Bausch Health Companies financials performed over time
Bausch Health Companies's quick ratio has decreased by 3.1% YoY
The debt has declined by 4.1% year-on-year
The debt to equity is up by 3.6% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.